The Manufacturers Life Insurance Company Reduces Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

The Manufacturers Life Insurance Company decreased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 5.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,936 shares of the medical instruments supplier’s stock after selling 101 shares during the period. The Manufacturers Life Insurance Company’s holdings in Mesa Laboratories were worth $255,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of MLAB. Conestoga Capital Advisors LLC boosted its stake in Mesa Laboratories by 8.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 573,037 shares of the medical instruments supplier’s stock worth $75,566,000 after purchasing an additional 43,927 shares during the period. Vanguard Group Inc. grew its holdings in Mesa Laboratories by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 382,856 shares of the medical instruments supplier’s stock valued at $50,487,000 after purchasing an additional 5,274 shares during the period. Raymond James Financial Inc. acquired a new position in Mesa Laboratories during the fourth quarter valued at approximately $32,677,000. Kennedy Capital Management LLC lifted its position in Mesa Laboratories by 13.2% during the fourth quarter. Kennedy Capital Management LLC now owns 74,606 shares of the medical instruments supplier’s stock valued at $9,838,000 after buying an additional 8,700 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of Mesa Laboratories by 9.3% during the fourth quarter. Principal Financial Group Inc. now owns 38,359 shares of the medical instruments supplier’s stock worth $5,058,000 after purchasing an additional 3,252 shares in the last quarter. Institutional investors and hedge funds own 90.60% of the company’s stock.

Insider Buying and Selling at Mesa Laboratories

In related news, CEO Gary M. Owens sold 21,000 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the transaction, the chief executive officer now owns 43,337 shares in the company, valued at approximately $5,369,887.67. This represents a 32.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 4.40% of the stock is owned by corporate insiders.

Mesa Laboratories Stock Up 0.9%

Shares of NASDAQ:MLAB opened at $122.42 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a 12-month low of $83.68 and a 12-month high of $155.12. The company has a fifty day simple moving average of $118.33 and a 200 day simple moving average of $126.83. The firm has a market cap of $665.23 million, a PE ratio of -2.65 and a beta of 0.97.

Mesa Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 dividend on an annualized basis and a yield of 0.52%. Mesa Laboratories’s dividend payout ratio is presently -1.38%.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.